Results 181 to 190 of about 35,568 (259)

The roles of salivary secretory IgA on the development of oral candidiasis. [PDF]

Front Oral Health
Zhou J, Wang J, Shen J, Lin Y, Kang L, Wang Y, Zhou Y, Liao G, Ren B.   +8 more
europepmc   +1 more source

Mold allergens and antigenic epitopes correlation with fungal diseases.

Current protein & peptide science, 2015
Singh, Bharat, Asif, Abdul R.
openaire   +2 more sources

Unveiling Gut Homeostasis Disruption in Sepsis: Towards an Integrated Mechanistic and Translational Roadmap

Cell Proliferation, Volume 59, Issue 8, August 2026.
Elucidating the contribution of gut‐organ axes will provide new insights for developing combined therapeutic strategies against sepsis‐associated multiple organ dysfunction. ABSTRACT Sepsis, a life‐threatening clinical syndrome precipitated by a maladaptive host response to infection, is associated with substantial morbidity and high mortality rates ...
Yichen Bao, Lin Qi, Guijun Zou, Xingpeng Yang, Yizhao Ma, Zhifu Li, Xiaohui Du, Pengyue Zhao   +7 more
wiley   +1 more source

Immune Camouflage in <i>Pythium insidiosum</i> Keratitis: A Hypothesis on Molecular Mimicry and Host Pattern Recognition Receptor Evasion. [PDF]

Clin Ophthalmol
Gurnani B, Kaur K.
europepmc   +1 more source

A Phase 2 Trial of Frexalimab, a CD40L Antagonist, in Adolescents and Adults With Recent‐Onset Type 1 Diabetes (FABULINUS): Rationale and Study Design

Diabetes, Obesity and Metabolism, Volume 28, Issue 8, Page 6584-6594, August 2026.
ABSTRACT Introduction Type 1 diabetes (T1D) is a chronic autoimmune disease, characterised by progressive destruction of the insulin‐producing pancreatic β‐cells. Preserving remaining β‐cells at the time of diagnosis may improve long‐term outcomes. Frexalimab is a humanised monoclonal antibody specific for CD40L undergoing evaluation for treatment of ...
Andriy Cherkas, Baerbel Rotthaeuser, Niels Porksen, Pascale Labard, My‐Liên Nguyên‐Pascal, Mathieu Coudert, Baptiste Berthou, Marie Baccara‐Dinet, Gabor Boka, Mark Peakman, Felix Reschke, Michael J. Haller   +11 more
wiley   +1 more source

Cell Surface Shaving-Based Proteomic Profiling of the Surfaceome in Pathogenic Microorganisms. [PDF]

Int J Mol Sci
Satala D, Kowalik K, Karkowska-Kuleta J.
europepmc   +1 more source

OX40/OX40L modulation: A target for regulating T cells in cutaneous inflammatory disorders

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 8, Page 1318-1331, August 2026.
OX40 and OX40L are a co‐stimulatory immune checkpoint pair. Modulation of this pair impacts multiple immune phenotypes and is an attractive target for immunotherapy in dermatological disorders. Trials are underway with the majority in atopic dermatitis and currently in phase 3 trials.
Aditya K. Gupta, Julia Steriopoulos, Vasiliki Economopoulos, Paradi Mirmirani, Vincent Piguet   +4 more
wiley   +1 more source

Cryptococcal Meningitis Treatment Beyond HIV: Recognizing the Need for Individualized Immune-Based Strategies. [PDF]

Clin Infect Dis
Yoon H, Pirofski LA, Boulware DR.
europepmc   +1 more source

The immunity paradox: how do plants survive without adaptive immunity?

The Plant Journal, Volume 127, Issue 3, August 2026.
SUMMARY Higher plants and mammals exist in similar microbial environments and face similar challenges from microbial pathogens. Both taxonomic groups encode proteins capable of recognizing and triggering responses to pathogens; however, their recognitional capacities differ substantially.
Peter Balint‐Kurti
wiley   +1 more source

Vaccine-Mediated Protection of Mice Against African and Asian Clinical Strains of <i>Cryptococcus neoformans</i>. [PDF]

J Fungi (Basel)
Carlson D, Wang R, Hastings Z, Oliveira LVN, Hester MM, Rodriguez N, Pedersen GK, Tenor JL, Perfect JR, Specht CA, Levitz SM.   +10 more
europepmc   +1 more source